Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological influences on aldosterone secretion.

R Garcia-Robles1, L M Ruilope

  • 1Service of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain.

Journal of Steroid Biochemistry
|January 1, 1987
PubMed
Summary

New factors influencing aldosterone secretion, including dopamine agonists and H2-receptor antagonists, are explored. Their effects offer potential new therapeutic strategies for aldosterone secretion disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2023
Same author

Oral health, hypertension and cardiovascular diseases.

Hipertension y riesgo vascular·2023
Same author

Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration.

Hipertension y riesgo vascular·2022
Same author

[2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension].

Hipertension y riesgo vascular·2022
Same author

2021 Spanish Society of Hypertension position statement about telemedicine.

Hipertension y riesgo vascular·2021
Same author

[Awareness, treatment and control of blood pressure according to place of recruitment and sex in the May Measure Month 2018 survey in Spain].

Hipertension y riesgo vascular·2020

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Classical modulators of aldosterone secretion are well-established.
  • Emerging factors influencing aldosterone secretion have been identified.
  • Understanding these new factors is crucial for therapeutic advancements.

Purpose of the Study:

  • To review novel factors affecting aldosterone secretion.
  • To examine the therapeutic potential of drugs targeting these factors.
  • To explore the role of dopamine agonists and H2-receptor antagonists.

Main Methods:

  • Literature review of studies on aldosterone secretion.
  • Analysis of the effects of specific drug classes.
  • Examination of clinical situations with altered aldosterone production.

Main Results:

  • Dopamine agonists can influence aldosterone secretion.
  • H2-receptor antagonists also impact aldosterone levels.
  • These effects are observed in both normal volunteers and specific clinical conditions.

Conclusions:

  • New drug targets for aldosterone secretion modulation exist.
  • Dopamine agonists and H2-receptor antagonists represent promising therapeutic avenues.
  • Further research into these agents could lead to novel treatments for aldosterone-related disorders.

Related Experiment Videos